PROGRAM DESCRIPTION: Skin cancers are considered advanced when they are observed to spread aggressively, demonstrate resistance to multiple treatments, or readily recur. These include those that are locally advanced and/or metastatic. Treatment regimens may include excision with or without sentinel lymph node biopsy or neck dissection, Mohs surgery, radiation therapy, chemotherapy, or immunotherapy, either alone or in combination. Surgery remains the mainstay of treatment for early-stage disease of all skin cancer types and may comprise one of multiple treatment modalities for more advanced disease. Advances in reconstruction have expanded our ability to restore form and function. The role of radiation therapy is often adjuvant and dependent on tumor type, extent, and cervical nodal disease. A myriad of new medical treatments have emerged which target specific mutations or harness facets of the immune system. As such, it is more critical than ever for the otolaryngologist to understand current treatment algorithms, the role of the immune system in emerging treatment paradigms, the mutational landscape that generates targeted therapy, and future directions of current research. This course will focus on 4 main skin cancer subtypes: melanoma, merkel cell carcinoma, squamous cell carcinoma, and basal cell carcinoma. We will highlight the similarities and differences in treatment approach based on pathology and extent of disease. A case-based format will be utilized to discuss the role of local therapies including surgery, reconstruction, and radiation and systemic therapies. A focused discussion of clinically-applicable biomarkers, mutation testing, emerging systemic treatments, and current research will provide a framework for the otolaryngologist to treat and counsel patients.OUTCOME OBJECTIVE 1: To review current treatment paradigms for advanced skin cancers of the head and neck.OUTCOME OBJECTIVE 2: To illustrate the use of surgical excision and reconstruction with appropriate use of sentinel node biopsy or neck dissectionOUTCOME OBJECTIVE 3: To review standard and novel systemic treatments and their interplay with the immune system and mutational landscape.BACKGROUND STATEMENT: Advanced skin cancers are well within the realm of the otolaryngologist s care. With the varied pathologies and myriad of new treatments, it is critical to understand the nuances of each, where each modality fits, and current treatment paradigms
- Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
- Activity Link: http://media.mycrowdwisdom.com.s3.amazonaws.com/aao-hnsf/2023_Annual_Meeting_Webcasts/23AMW2409481.mp4
- Start Date: 2023-10-01 05:00:00
- End Date: 2023-10-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Head & Neck